SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® (nivolumab and hyaluronidase‑nvhy), Bristol Myers Squibb'.

businesswire.com - 2026-07-14 08:00:00

A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.

zacks.com - 2026-07-09 14:55:16

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides.

businesswire.com - 2026-07-08 08:00:00

[url="]Alpha and Omega Semiconductor Limited[/url] (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range of discrete power devices,

gurufocus.com - 2026-07-07 11:00:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to.

businesswire.com - 2026-07-01 08:00:00

Agilent (A) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-26 12:31:14

Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical ("Biocare"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. ("Agilent", NYSE:A).

globenewswire.com - 2026-06-25 08:06:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent's Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st.

businesswire.com - 2026-06-25 08:00:00

Canadian Apartment Properties REIT trades at 15x AFFO and nearly 40% below NAV, offering compelling value. Q1 AFFO per share declined just 1.5% to C$0.513, with a strong 70% payout ratio and robust distribution coverage. Active buybacks and retained AFFO (~C$100 million/year) support growth initiatives and the development pipeline.

seekingalpha.com - 2026-06-24 10:30:00

Alert: Claims Focus on Alleged Misrepresentations About Weakening Veterinarian Adoption and Prescription Trends That Cost ZTS Investors $23.91 Per Share Following the Final Disclosure NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Zoetis Inc. (NYSE: ZTS) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026.

prnewswire.com - 2026-06-24 10:09:00

Alert: Claims Focus on Alleged Misrepresentations About the Durability of Verra Mobility's Largest Customer Contract and the $35 Million Revenue Hole Left by Avis Budget Group's Termination NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Verra Mobility Corporation (NASDAQ: VRRM) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased VRRM securities between February 24, 2026 and May 26, 2026.

prnewswire.com - 2026-06-24 10:09:00

Alert: Claims Focus on Alleged Inventory Mismanagement and Production Curtailments That Drove $130 Million in Projected 2026 EBITDA Losses NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Graphic Packaging Holding Company (NYSE: GPK) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased GPK securities between February 4, 2025 and February 2, 2026.

prnewswire.com - 2026-06-24 10:07:00

Freehold, NJ, June 24, 2026 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, today expressed strong support for the 21st Century ROAD to Housing Act, comprehensive bipartisan legislation designed to address the nation's housing shortage by expanding supply, reducing costs, and modernizing regulations for manufactured housing.

globenewswire.com - 2026-06-24 06:45:00

NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, will release financial results for the second quarter of 2026 on Thursday, July 30, 2026, at approximately 7:00 AM EDT. In addition, Tradeweb will host a conference call for investors. WHO: Billy Hult, CEO Sara Furber, CFO Ashley Serrao, Head of Treasury, FP&A and IR   WHAT: A discussion of financial results for the second quarter of 2026 followed by a question-and-answ.

businesswire.com - 2026-06-23 14:00:00

FREMONT, Calif.--(BUSINESS WIRE)-- #Audi--The Presidio Group LLC (“Presidio”), an independent merchant banking firm focused on mergers and acquisitions, capital raising and investments in the automotive retail and consumer mobility sectors, exclusively advised Fletcher Jones Automotive Group (“Fletcher Jones”) on the sale of Fletcher Jones Motorcars (Mercedes-Benz) of Fremont, Audi Fremont and Porsche Fremont in Fremont, Calif., and their related real estate, to AutoNation Inc. (“AutoNation”) (“NYSE: A.

businesswire.com - 2026-06-23 10:20:00

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Microsoft Corporation (NASDAQ: MSFT) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Microsoft securities between May 1, 2025 and January 28, 2026.

globenewswire.com - 2026-06-23 10:13:00

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Erasca, Inc. (NASDAQ: ERAS) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased ERAS securities between January 14, 2025 and April 26, 2026.

globenewswire.com - 2026-06-23 10:09:00

Investors need to pay close attention to A stock based on the movements in the options market lately.

zacks.com - 2026-06-22 10:41:27

iShares US Large Cap Premium Income Active ETF (BALI) targets conservative, income-focused investors seeking high yield with lower volatility than the broader market. BALI offers a 7.8% distribution yield and a low 0.35% expense ratio, outperforming some covered call peers in recent periods while maintaining a conservative cost structure. The ETF's options overlay strategy caps upside, leading to underperformance in strong bull markets and heightened risk of NAV decline and payout volatility in prolonged bear markets.

seekingalpha.com - 2026-06-19 09:30:00

The iShares Large Cap Core Active ETF is a highly concentrated, actively managed fund that has outperformed many similar ETFs since its inception in October 2023. BLCR's managers intentionally deviate from consensus, focusing on long-term earnings growth and momentum, differentiating it from passive Index funds. Fundamental analysis reveals an expensive portfolio, both relative to its peers and itself, based on its 5Y average P/E. Quality is also behind another active BlackRock ETF that I prefer.

seekingalpha.com - 2026-06-18 14:52:28

Alert: Claims Focus on Alleged Misrepresentations About Regencell's $1 Million R&D Budget Versus $14 Billion Market Valuation NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities of a pending securities class action. THE CASE: A class action was filed, seeking to recover damages for investors who purchased Regencell securities between October 28, 2024 and October 31, 2025.

prnewswire.com - 2026-06-18 10:09:00

Critical Information: $1.57 Per Share in Combined Losses Quantifies Alleged Investor Damages After Lucid Group Concealed a 29-Day Delivery Halt That Erased Significant Market Value NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Lucid Group, Inc. (NASDAQ: LCID) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Lucid securities between February 25, 2026 and April 13, 2026.

prnewswire.com - 2026-06-18 10:07:00

Sportradar's SEC Filings Acknowledged Regulatory Risks in Generic Terms While the Company Allegedly Operated a Black-Market Revenue Pipeline Spanning Six Prohibited Countries NEW YORK, June 17, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Sportradar Group AG (NASDAQ: SRAD) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased SRAD securities between November 7, 2024, and April 21, 2026.

prnewswire.com - 2026-06-17 10:15:00

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding RGC: A $14 Billion Market Valuation Built on Zero Revenue and Twelve Employees Now Faces a DOJ Investigation, Creating Potential Fiduciary Exposure NEW YORK, June 17, 2026 /PRNewswire/ -- Institutional investors holding positions in Regencell Bioscience Holdings Limited (NASDAQ: RGC) during the period October 28, 2024 through October 31, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment.

prnewswire.com - 2026-06-17 10:15:00

Vanguard FTSE Canadian High Dividend Yield Idx ETF (VDY:CA) is rated HOLD, offering reliable income but high sector concentration in financials and energy. VDY's strategy prioritizes forecast dividend yield over growth or diversification, resulting in strong historical returns but elevated concentration risk. With a 3.17% yield and 0.22% expense ratio, VDY suits income-focused investors comfortable with sector bets, but lacks upside catalysts for new buyers.

seekingalpha.com - 2026-06-12 11:45:49

OKLO wins DOE approval for Aurora-INL's preliminary safety analysis, advancing its first fast fission power plant under the Reactor Pilot Program.

zacks.com - 2026-06-12 09:06:17

Alert: Claims Focus on Alleged Failures in Internal Controls Over Confidential Information and Tax Compliance That Cost POET Investors $7.15 Per Share NEW YORK, June 11, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of POET Technologies Inc. (NASDAQ: POET) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased POET securities between April 1, 2026 and April 27, 2026.

prnewswire.com - 2026-06-11 09:35:00

Critical Information: SES AI's $0.63 Per-Share Collapse Quantifies Alleged Investor Damages as Phantom Deals and Circular Revenue Schemes Unravel NEW YORK, June 11, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of SES AI Corporation (NYSE: SES) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased SES securities between January 29, 2025 and March 4, 2026.

prnewswire.com - 2026-06-11 09:35:00

Alert: Claims Focus on Alleged Misrepresentations About BitGo's Digital Asset Sales Margin Compression and Bitcoin Treasury Losses NEW YORK, June 11, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of BitGo Holdings, Inc. (NYSE: BTGO) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased BTGO securities between January 22, 2025 and May 13, 2026.

prnewswire.com - 2026-06-11 09:35:00

Alert: Claims Focus on AeroVironment's Reliance on a Single-Vendor Bespoke Contract That Allegedly Left Investors Exposed When the Space Force Shifted to Multi-Vendor Commercial Solutions NEW YORK, June 11, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of AeroVironment, Inc. (NASDAQ: AVAV) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased AVAV securities between June 25, 2025 and March 10, 2026.

prnewswire.com - 2026-06-11 09:35:00

Alert: Claims Focus on Alleged Misrepresentations About Badger Meter's AMI Transition and Short-Cycle Municipal Ordering Practices NEW YORK, June 11, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Badger Meter, Inc. (NYSE: BMI) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased BMI securities between April 18, 2024 and April 16, 2026.

prnewswire.com - 2026-06-11 09:00:00

Alert: Claims Focus on Alleged Misrepresentations About Weakening Veterinarian Adoption and Prescription Trends That Cost ZTS Investors $23.91 Per Share Following the Final Disclosure NEW YORK, June 11, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Zoetis Inc. (NYSE: ZTS) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026.

prnewswire.com - 2026-06-11 09:00:00

Agilent Technologies, Inc. (A) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-03 17:22:00

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company's products, operations, and customer workflows. “AI is a top priority, and this partnership reflects both our ambition and our execution commitment — to build the enduring capability, operating model, and capacity required to consistently deliver AI‑driven innovation.

businesswire.com - 2026-06-03 07:00:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the expanded use of PD-L1 IHC 22C3 pharmDx, Code GE006, for use on the Dako Omnis platform to aid in identifying patients in the United States with esophageal squamous cell carcinoma (ESCC)3, triple-negative breast cancer (TNBC)4, cervical cancer5, and gastric or gastroesophageal junction (GEJ) adenocarcinoma6, who may be eligible for treatment.

businesswire.com - 2026-06-02 16:15:00

Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

zacks.com - 2026-06-01 10:16:12

A beat Q2 estimates and raised its fiscal 2026 outlook. It says its Ignite operating system is driving more durable gains in pricing, execution and margins.

zacks.com - 2026-06-01 08:01:16

The healthcare solutions specialist is also on track to top analyst estimates for the full year. The company saw growth in several key client segments.

fool.com - 2026-05-28 20:07:19

U.S. stocks were higher, with the Nasdaq Composite gaining around 200 points on Thursday.

benzinga.com - 2026-05-28 12:42:41

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of OpenLab Sync, a new Lab Execution System (LES) that enables laboratories to digitally connect scientific workflows from method design through execution at the bench. OpenLab Sync extends Agilent's OpenLab laboratory informatics portfolio beyond traditional data and sample management, enabling guided, standardized, and traceable execution of laboratory work in regulated environments. As.

businesswire.com - 2026-05-28 08:00:00

Agilent Technologies, Inc. (A) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-28 05:40:18

Agilent Technologies NYSE: A raised its fiscal 2026 outlook after reporting stronger-than-expected second-quarter results, with management pointing to broad-based demand, instrument replacement momentum, pricing actions and operational gains from its Ignite operating system.

marketbeat.com - 2026-05-27 19:07:21

The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com - 2026-05-27 19:01:09

Agilent Technologies (A) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.31 per share a year ago.

zacks.com - 2026-05-27 18:20:22

Life sciences firm Agilent Technologies raised its 2026 adjusted profit forecast on Wednesday, anticipating ​strong demand for its medical tools and ‌equipment used in lab research and diagnostic services.

reuters.com - 2026-05-27 16:09:27

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.83 billion for the second quarter ended April 30, 2026, representing growth of 10.0% reported and up 6.3% core(1) compared with the second quarter of 2025. Second-quarter GAAP net income was $339 million, or $1.20 per share. This compares with $215 million, or $0.75 per share, in the second quarter of 2025. Non-GAAP net income(3) was $423 million, or $1.49 per share, during the quarter, compar.

businesswire.com - 2026-05-27 16:05:00

Agilent Technologies Inc. (NYSE: A) today announced the release of a new [url="]multi-attribute method (MAM)[/url] workflow designed to help pharmaceutical and

gurufocus.com - 2026-05-26 09:00:00

Agilent Technologies Inc. (NYSE: A) today announced the launch of the new [url="]8890B GC[/url] and [url="]8860B GC[/url] with GC Assist. GC Assist is the new,

gurufocus.com - 2026-05-26 09:00:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the new 8890B GC and 8860B GC with GC Assist. GC Assist is the new, advanced instrument intelligence that provides system monitoring, built-in troubleshooting, and remote connectivity to analytical instrumentation within the laboratory's secure network. These systems enable higher performance and productivity across gas chromatography analyses. The new systems are designed to help laboratorie.

businesswire.com - 2026-05-26 08:00:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC/HRMS) in routine, regulated testing environments. The Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational ba.

businesswire.com - 2026-05-26 08:00:00